 | • レポートコード：GIR-107A15053 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、オキサリプラチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。オキサリプラチンの種類別市場規模（マンニトール、ブドウ糖液、乳糖液、その他）、用途別市場規模（結腸直腸がん、胃がん、卵巣がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・オキサリプラチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi-Aventis、Yakult honsha、Dr Reddy's laboratories、Sun Pharmaceutical、Teva、Fresenius Kabi、Hospira、Mylan、Jiangsu Hengrui Medicine、Nanjing Pharmaceutical Factory、Jiangsu Aosaikang Pharmaceutical、Qilu Pharmaceutical、Hisun Pharmaceutical、Lunan Pharmaceutical、Luoxin、Halfsky Pharmacy、YRPG、Hainan Jinrui Pharmaceutical、Jari Pharmaceutical、Chiatai Tianqing ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：マンニトール、ブドウ糖液、乳糖液、その他 ・用途別分析2016年-2026年：結腸直腸がん、胃がん、卵巣がん、その他 ・オキサリプラチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・オキサリプラチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・オキサリプラチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・オキサリプラチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・オキサリプラチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oxaliplatin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oxaliplatin size is estimated to be USD 1253.8 million in 2026 from USD 905.4 million in 2020, with a change XX% between 2020 and 2021. The global Oxaliplatin market size is expected to grow at a CAGR of 8.5% for the next five years.
Market segmentation
Oxaliplatin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Mannitol
Glucose Solution
Lactose Solution
Others
Market segment by Application, can be divided into
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Others
Market segment by players, this report covers
Sanofi-Aventis
Yakult honsha
Dr Reddy’s laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Oxaliplatin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Oxaliplatin, with revenue, gross margin and global market share of Oxaliplatin from 2019 to 2021.
Chapter 3, the Oxaliplatin competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Oxaliplatin market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Oxaliplatin research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Oxaliplatin
1.2 Classification of Oxaliplatin by Type
1.2.1 Overview: Global Oxaliplatin Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Oxaliplatin Revenue Market Share by Type in 2020
1.2.3 Mannitol
1.2.4 Glucose Solution
1.2.5 Lactose Solution
1.2.6 Others
1.3 Global Oxaliplatin Market by Application
1.3.1 Overview: Global Oxaliplatin Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Global Oxaliplatin Market Size & Forecast
1.5 Global Oxaliplatin Market Size and Forecast by Region
1.5.1 Global Oxaliplatin Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Oxaliplatin Market Size by Region, (2016-2021)
1.5.3 North America Oxaliplatin Market Size and Prospect (2016-2026)
1.5.4 Europe Oxaliplatin Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Oxaliplatin Market Size and Prospect (2016-2026)
1.5.6 South America Oxaliplatin Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Oxaliplatin Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oxaliplatin Market Drivers
1.6.2 Oxaliplatin Market Restraints
1.6.3 Oxaliplatin Trends Analysis
2 Company Profiles
2.1 Sanofi-Aventis
2.1.1 Sanofi-Aventis Details
2.1.2 Sanofi-Aventis Major Business
2.1.3 Sanofi-Aventis Oxaliplatin Product and Solutions
2.1.4 Sanofi-Aventis Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Sanofi-Aventis Recent Developments and Future Plans
2.2 Yakult honsha
2.2.1 Yakult honsha Details
2.2.2 Yakult honsha Major Business
2.2.3 Yakult honsha Oxaliplatin Product and Solutions
2.2.4 Yakult honsha Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Yakult honsha Recent Developments and Future Plans
2.3 Dr Reddy’s laboratories
2.3.1 Dr Reddy’s laboratories Details
2.3.2 Dr Reddy’s laboratories Major Business
2.3.3 Dr Reddy’s laboratories Oxaliplatin Product and Solutions
2.3.4 Dr Reddy’s laboratories Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Dr Reddy’s laboratories Recent Developments and Future Plans
2.4 Sun Pharmaceutical
2.4.1 Sun Pharmaceutical Details
2.4.2 Sun Pharmaceutical Major Business
2.4.3 Sun Pharmaceutical Oxaliplatin Product and Solutions
2.4.4 Sun Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sun Pharmaceutical Recent Developments and Future Plans
2.5 Teva
2.5.1 Teva Details
2.5.2 Teva Major Business
2.5.3 Teva Oxaliplatin Product and Solutions
2.5.4 Teva Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Teva Recent Developments and Future Plans
2.6 Fresenius Kabi
2.6.1 Fresenius Kabi Details
2.6.2 Fresenius Kabi Major Business
2.6.3 Fresenius Kabi Oxaliplatin Product and Solutions
2.6.4 Fresenius Kabi Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Fresenius Kabi Recent Developments and Future Plans
2.7 Hospira
2.7.1 Hospira Details
2.7.2 Hospira Major Business
2.7.3 Hospira Oxaliplatin Product and Solutions
2.7.4 Hospira Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Hospira Recent Developments and Future Plans
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Oxaliplatin Product and Solutions
2.8.4 Mylan Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Mylan Recent Developments and Future Plans
2.9 Jiangsu Hengrui Medicine
2.9.1 Jiangsu Hengrui Medicine Details
2.9.2 Jiangsu Hengrui Medicine Major Business
2.9.3 Jiangsu Hengrui Medicine Oxaliplatin Product and Solutions
2.9.4 Jiangsu Hengrui Medicine Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Jiangsu Hengrui Medicine Recent Developments and Future Plans
2.10 Nanjing Pharmaceutical Factory
2.10.1 Nanjing Pharmaceutical Factory Details
2.10.2 Nanjing Pharmaceutical Factory Major Business
2.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Product and Solutions
2.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Nanjing Pharmaceutical Factory Recent Developments and Future Plans
2.11 Jiangsu Aosaikang Pharmaceutical
2.11.1 Jiangsu Aosaikang Pharmaceutical Details
2.11.2 Jiangsu Aosaikang Pharmaceutical Major Business
2.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product and Solutions
2.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Jiangsu Aosaikang Pharmaceutical Recent Developments and Future Plans
2.12 Qilu Pharmaceutical
2.12.1 Qilu Pharmaceutical Details
2.12.2 Qilu Pharmaceutical Major Business
2.12.3 Qilu Pharmaceutical Oxaliplatin Product and Solutions
2.12.4 Qilu Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Qilu Pharmaceutical Recent Developments and Future Plans
2.13 Hisun Pharmaceutical
2.13.1 Hisun Pharmaceutical Details
2.13.2 Hisun Pharmaceutical Major Business
2.13.3 Hisun Pharmaceutical Oxaliplatin Product and Solutions
2.13.4 Hisun Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Hisun Pharmaceutical Recent Developments and Future Plans
2.14 Lunan Pharmaceutical
2.14.1 Lunan Pharmaceutical Details
2.14.2 Lunan Pharmaceutical Major Business
2.14.3 Lunan Pharmaceutical Oxaliplatin Product and Solutions
2.14.4 Lunan Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Lunan Pharmaceutical Recent Developments and Future Plans
2.15 Luoxin
2.15.1 Luoxin Details
2.15.2 Luoxin Major Business
2.15.3 Luoxin Oxaliplatin Product and Solutions
2.15.4 Luoxin Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Luoxin Recent Developments and Future Plans
2.16 Halfsky Pharmacy
2.16.1 Halfsky Pharmacy Details
2.16.2 Halfsky Pharmacy Major Business
2.16.3 Halfsky Pharmacy Oxaliplatin Product and Solutions
2.16.4 Halfsky Pharmacy Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Halfsky Pharmacy Recent Developments and Future Plans
2.17 YRPG
2.17.1 YRPG Details
2.17.2 YRPG Major Business
2.17.3 YRPG Oxaliplatin Product and Solutions
2.17.4 YRPG Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 YRPG Recent Developments and Future Plans
2.18 Hainan Jinrui Pharmaceutical
2.18.1 Hainan Jinrui Pharmaceutical Details
2.18.2 Hainan Jinrui Pharmaceutical Major Business
2.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Product and Solutions
2.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Hainan Jinrui Pharmaceutical Recent Developments and Future Plans
2.19 Jari Pharmaceutical
2.19.1 Jari Pharmaceutical Details
2.19.2 Jari Pharmaceutical Major Business
2.19.3 Jari Pharmaceutical Oxaliplatin Product and Solutions
2.19.4 Jari Pharmaceutical Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Jari Pharmaceutical Recent Developments and Future Plans
2.20 Chiatai Tianqing
2.20.1 Chiatai Tianqing Details
2.20.2 Chiatai Tianqing Major Business
2.20.3 Chiatai Tianqing Oxaliplatin Product and Solutions
2.20.4 Chiatai Tianqing Oxaliplatin Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Chiatai Tianqing Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oxaliplatin Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Oxaliplatin Players Market Share
3.2.2 Top 10 Oxaliplatin Players Market Share
3.2.3 Market Competition Trend
3.3 Oxaliplatin Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Oxaliplatin Revenue and Market Share by Type (2016-2021)
4.2 Global Oxaliplatin Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Oxaliplatin Revenue Market Share by Application (2016-2021)
5.2 Oxaliplatin Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Oxaliplatin Revenue by Type (2016-2026)
6.2 North America Oxaliplatin Revenue by Application (2016-2026)
6.3 North America Oxaliplatin Market Size by Country
6.3.1 North America Oxaliplatin Revenue by Country (2016-2026)
6.3.2 United States Oxaliplatin Market Size and Forecast (2016-2026)
6.3.3 Canada Oxaliplatin Market Size and Forecast (2016-2026)
6.3.4 Mexico Oxaliplatin Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Oxaliplatin Revenue by Type (2016-2026)
7.2 Europe Oxaliplatin Revenue by Application (2016-2026)
7.3 Europe Oxaliplatin Market Size by Country
7.3.1 Europe Oxaliplatin Revenue by Country (2016-2026)
7.3.2 Germany Oxaliplatin Market Size and Forecast (2016-2026)
7.3.3 France Oxaliplatin Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Oxaliplatin Market Size and Forecast (2016-2026)
7.3.5 Russia Oxaliplatin Market Size and Forecast (2016-2026)
7.3.6 Italy Oxaliplatin Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Oxaliplatin Revenue by Type (2016-2026)
8.2 Asia-Pacific Oxaliplatin Revenue by Application (2016-2026)
8.3 Asia-Pacific Oxaliplatin Market Size by Region
8.3.1 Asia-Pacific Oxaliplatin Revenue by Region (2016-2026)
8.3.2 China Oxaliplatin Market Size and Forecast (2016-2026)
8.3.3 Japan Oxaliplatin Market Size and Forecast (2016-2026)
8.3.4 South Korea Oxaliplatin Market Size and Forecast (2016-2026)
8.3.5 India Oxaliplatin Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Oxaliplatin Market Size and Forecast (2016-2026)
8.3.7 Australia Oxaliplatin Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Oxaliplatin Revenue by Type (2016-2026)
9.2 South America Oxaliplatin Revenue by Application (2016-2026)
9.3 South America Oxaliplatin Market Size by Country
9.3.1 South America Oxaliplatin Revenue by Country (2016-2026)
9.3.2 Brazil Oxaliplatin Market Size and Forecast (2016-2026)
9.3.3 Argentina Oxaliplatin Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Oxaliplatin Revenue by Type (2016-2026)
10.2 Middle East & Africa Oxaliplatin Revenue by Application (2016-2026)
10.3 Middle East & Africa Oxaliplatin Market Size by Country
10.3.1 Middle East & Africa Oxaliplatin Revenue by Country (2016-2026)
10.3.2 Turkey Oxaliplatin Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Oxaliplatin Market Size and Forecast (2016-2026)
10.3.4 UAE Oxaliplatin Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Oxaliplatin Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Oxaliplatin Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Oxaliplatin Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Oxaliplatin Revenue (USD Million) by Region (2016-2021)
Table 5. Global Oxaliplatin Revenue Market Share by Region (2021-2026)
Table 6. Sanofi-Aventis Corporate Information, Head Office, and Major Competitors
Table 7. Sanofi-Aventis Major Business
Table 8. Sanofi-Aventis Oxaliplatin Product and Solutions
Table 9. Sanofi-Aventis Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Yakult honsha Corporate Information, Head Office, and Major Competitors
Table 11. Yakult honsha Major Business
Table 12. Yakult honsha Oxaliplatin Product and Solutions
Table 13. Yakult honsha Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Dr Reddy's laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Dr Reddy's laboratories Major Business
Table 16. Dr Reddy's laboratories Oxaliplatin Product and Solutions
Table 17. Dr Reddy's laboratories Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 19. Sun Pharmaceutical Major Business
Table 20. Sun Pharmaceutical Oxaliplatin Product and Solutions
Table 21. Sun Pharmaceutical Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Teva Corporate Information, Head Office, and Major Competitors
Table 23. Teva Major Business
Table 24. Teva Oxaliplatin Product and Solutions
Table 25. Teva Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Fresenius Kabi Corporate Information, Head Office, and Major Competitors
Table 27. Fresenius Kabi Major Business
Table 28. Fresenius Kabi Oxaliplatin Product and Solutions
Table 29. Fresenius Kabi Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Hospira Corporate Information, Head Office, and Major Competitors
Table 31. Hospira Major Business
Table 32. Hospira Oxaliplatin Product and Solutions
Table 33. Hospira Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Mylan Corporate Information, Head Office, and Major Competitors
Table 35. Mylan Major Business
Table 36. Mylan Oxaliplatin Product and Solutions
Table 37. Mylan Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Jiangsu Hengrui Medicine Corporate Information, Head Office, and Major Competitors
Table 39. Jiangsu Hengrui Medicine Major Business
Table 40. Jiangsu Hengrui Medicine Oxaliplatin Product and Solutions
Table 41. Jiangsu Hengrui Medicine Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Nanjing Pharmaceutical Factory Corporate Information, Head Office, and Major Competitors
Table 43. Nanjing Pharmaceutical Factory Major Business
Table 44. Nanjing Pharmaceutical Factory Oxaliplatin Product and Solutions
Table 45. Nanjing Pharmaceutical Factory Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Jiangsu Aosaikang Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 47. Jiangsu Aosaikang Pharmaceutical Major Business
Table 48. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product and Solutions
Table 49. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Qilu Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 51. Qilu Pharmaceutical Major Business
Table 52. Qilu Pharmaceutical Oxaliplatin Product and Solutions
Table 53. Qilu Pharmaceutical Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Hisun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 55. Hisun Pharmaceutical Major Business
Table 56. Hisun Pharmaceutical Oxaliplatin Product and Solutions
Table 57. Hisun Pharmaceutical Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Lunan Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 59. Lunan Pharmaceutical Major Business
Table 60. Lunan Pharmaceutical Oxaliplatin Product and Solutions
Table 61. Lunan Pharmaceutical Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Luoxin Corporate Information, Head Office, and Major Competitors
Table 63. Luoxin Major Business
Table 64. Luoxin Oxaliplatin Product and Solutions
Table 65. Luoxin Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Halfsky Pharmacy Corporate Information, Head Office, and Major Competitors
Table 67. Halfsky Pharmacy Major Business
Table 68. Halfsky Pharmacy Oxaliplatin Product and Solutions
Table 69. Halfsky Pharmacy Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. YRPG Corporate Information, Head Office, and Major Competitors
Table 71. YRPG Major Business
Table 72. YRPG Oxaliplatin Product and Solutions
Table 73. YRPG Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Hainan Jinrui Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 75. Hainan Jinrui Pharmaceutical Major Business
Table 76. Hainan Jinrui Pharmaceutical Oxaliplatin Product and Solutions
Table 77. Hainan Jinrui Pharmaceutical Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Jari Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 79. Jari Pharmaceutical Major Business
Table 80. Jari Pharmaceutical Oxaliplatin Product and Solutions
Table 81. Jari Pharmaceutical Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Chiatai Tianqing Corporate Information, Head Office, and Major Competitors
Table 83. Chiatai Tianqing Major Business
Table 84. Chiatai Tianqing Oxaliplatin Product and Solutions
Table 85. Chiatai Tianqing Oxaliplatin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Global Oxaliplatin Revenue (USD Million) by Players (2019-2021)
Table 87. Global Oxaliplatin Revenue Share by Players (2019-2021)
Table 88. Breakdown of Oxaliplatin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Oxaliplatin Players Head Office, Products and Services Provided
Table 90. Oxaliplatin Mergers & Acquisitions in the Past Five Years
Table 91. Oxaliplatin New Entrants and Expansion Plans
Table 92. Global Oxaliplatin Revenue (USD Million) by Type (2016-2021)
Table 93. Global Oxaliplatin Revenue Share by Type (2016-2021)
Table 94. Global Oxaliplatin Revenue Forecast by Type (2021-2026)
Table 95. Global Oxaliplatin Revenue by Application (2016-2021)
Table 96. Global Oxaliplatin Revenue Forecast by Application (2021-2026)
Table 97. North America Oxaliplatin Revenue by Type (2016-2021) & (USD Million)
Table 98. North America Oxaliplatin Revenue by Type (2021-2026) & (USD Million)
Table 99. North America Oxaliplatin Revenue by Application (2016-2021) & (USD Million)
Table 100. North America Oxaliplatin Revenue by Application (2021-2026) & (USD Million)
Table 101. North America Oxaliplatin Revenue by Country (2016-2021) & (USD Million)
Table 102. North America Oxaliplatin Revenue by Country (2021-2026) & (USD Million)
Table 103. Europe Oxaliplatin Revenue by Type (2016-2021) & (USD Million)
Table 104. Europe Oxaliplatin Revenue by Type (2021-2026) & (USD Million)
Table 105. Europe Oxaliplatin Revenue by Application (2016-2021) & (USD Million)
Table 106. Europe Oxaliplatin Revenue by Application (2021-2026) & (USD Million)
Table 107. Europe Oxaliplatin Revenue by Country (2016-2021) & (USD Million)
Table 108. Europe Oxaliplatin Revenue by Country (2021-2026) & (USD Million)
Table 109. Asia-Pacific Oxaliplatin Revenue by Type (2016-2021) & (USD Million)
Table 110. Asia-Pacific Oxaliplatin Revenue by Type (2021-2026) & (USD Million)
Table 111. Asia-Pacific Oxaliplatin Revenue by Application (2016-2021) & (USD Million)
Table 112. Asia-Pacific Oxaliplatin Revenue by Application (2021-2026) & (USD Million)
Table 113. Asia-Pacific Oxaliplatin Revenue by Region (2016-2021) & (USD Million)
Table 114. Asia-Pacific Oxaliplatin Revenue by Region (2021-2026) & (USD Million)
Table 115. South America Oxaliplatin Revenue by Type (2016-2021) & (USD Million)
Table 116. South America Oxaliplatin Revenue by Type (2021-2026) & (USD Million)
Table 117. South America Oxaliplatin Revenue by Application (2016-2021) & (USD Million)
Table 118. South America Oxaliplatin Revenue by Application (2021-2026) & (USD Million)
Table 119. South America Oxaliplatin Revenue by Country (2016-2021) & (USD Million)
Table 120. South America Oxaliplatin Revenue by Country (2021-2026) & (USD Million)
Table 121. Middle East & Africa Oxaliplatin Revenue by Type (2016-2021) & (USD Million)
Table 122. Middle East & Africa Oxaliplatin Revenue by Type (2021-2026) & (USD Million)
Table 123. Middle East & Africa Oxaliplatin Revenue by Application (2016-2021) & (USD Million)
Table 124. Middle East & Africa Oxaliplatin Revenue by Application (2021-2026) & (USD Million)
Table 125. Middle East & Africa Oxaliplatin Revenue by Country (2016-2021) & (USD Million)
Table 126. Middle East & Africa Oxaliplatin Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Oxaliplatin Picture
Figure 2. Global Oxaliplatin Revenue Market Share by Type in 2020
Figure 3. Mannitol
Figure 4. Glucose Solution
Figure 5. Lactose Solution
Figure 6. Others
Figure 7. Oxaliplatin Revenue Market Share by Application in 2020
Figure 8. Colorectal Cancer Picture
Figure 9. Stomach Cancer Picture
Figure 10. Ovarian Cancer Picture
Figure 11. Others Picture
Figure 12. Global Oxaliplatin Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Oxaliplatin Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Oxaliplatin Revenue Market Share by Region (2016-2026)
Figure 15. Global Oxaliplatin Revenue Market Share by Region in 2020
Figure 16. North America Oxaliplatin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Oxaliplatin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Oxaliplatin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Oxaliplatin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Oxaliplatin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Oxaliplatin Market Drivers
Figure 22. Oxaliplatin Market Restraints
Figure 23. Oxaliplatin Market Trends
Figure 24. Sanofi-Aventis Recent Developments and Future Plans
Figure 25. Yakult honsha Recent Developments and Future Plans
Figure 26. Dr Reddy's laboratories Recent Developments and Future Plans
Figure 27. Sun Pharmaceutical Recent Developments and Future Plans
Figure 28. Teva Recent Developments and Future Plans
Figure 29. Fresenius Kabi Recent Developments and Future Plans
Figure 30. Hospira Recent Developments and Future Plans
Figure 31. Mylan Recent Developments and Future Plans
Figure 32. Jiangsu Hengrui Medicine Recent Developments and Future Plans
Figure 33. Nanjing Pharmaceutical Factory Recent Developments and Future Plans
Figure 34. Jiangsu Aosaikang Pharmaceutical Recent Developments and Future Plans
Figure 35. Qilu Pharmaceutical Recent Developments and Future Plans
Figure 36. Hisun Pharmaceutical Recent Developments and Future Plans
Figure 37. Lunan Pharmaceutical Recent Developments and Future Plans
Figure 38. Luoxin Recent Developments and Future Plans
Figure 39. Halfsky Pharmacy Recent Developments and Future Plans
Figure 40. YRPG Recent Developments and Future Plans
Figure 41. Hainan Jinrui Pharmaceutical Recent Developments and Future Plans
Figure 42. Jari Pharmaceutical Recent Developments and Future Plans
Figure 43. Chiatai Tianqing Recent Developments and Future Plans
Figure 44. Global Oxaliplatin Revenue Share by Players in 2020
Figure 45. Oxaliplatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 46. Global Top 3 Players Oxaliplatin Revenue Market Share in 2020
Figure 47. Global Top 10 Players Oxaliplatin Revenue Market Share in 2020
Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 49. Global Oxaliplatin Revenue Share by Type in 2020
Figure 50. Global Oxaliplatin Market Share Forecast by Type (2021-2026)
Figure 51. Global Oxaliplatin Revenue Share by Application in 2020
Figure 52. Global Oxaliplatin Market Share Forecast by Application (2021-2026)
Figure 53. North America Oxaliplatin Sales Market Share by Type (2016-2026)
Figure 54. North America Oxaliplatin Sales Market Share by Application (2016-2026)
Figure 55. North America Oxaliplatin Revenue Market Share by Country (2016-2026)
Figure 56. United States Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Canada Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Mexico Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Europe Oxaliplatin Sales Market Share by Type (2016-2026)
Figure 60. Europe Oxaliplatin Sales Market Share by Application (2016-2026)
Figure 61. Europe Oxaliplatin Revenue Market Share by Country (2016-2026)
Figure 62. Germany Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. France Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. United Kingdom Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Russia Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Italy Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Asia-Pacific Oxaliplatin Sales Market Share by Type (2016-2026)
Figure 68. Asia-Pacific Oxaliplatin Sales Market Share by Application (2016-2026)
Figure 69. Asia-Pacific Oxaliplatin Revenue Market Share by Region (2016-2026)
Figure 70. China Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Japan Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. South Korea Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. India Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Southeast Asia Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Australia Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South America Oxaliplatin Sales Market Share by Type (2016-2026)
Figure 77. South America Oxaliplatin Sales Market Share by Application (2016-2026)
Figure 78. South America Oxaliplatin Revenue Market Share by Country (2016-2026)
Figure 79. Brazil Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Argentina Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Middle East and Africa Oxaliplatin Sales Market Share by Type (2016-2026)
Figure 82. Middle East and Africa Oxaliplatin Sales Market Share by Application (2016-2026)
Figure 83. Middle East and Africa Oxaliplatin Revenue Market Share by Country (2016-2026)
Figure 84. Turkey Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Saudi Arabia Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. UAE Oxaliplatin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 87. Methodology
Figure 88. Research Process and Data Source
世界のオキサリプラチンAPI市場 2021：企業別、地域別、種類・用途別 The Oxaliplatin API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…- 世界の結腸直腸がんスクリーニング市場 2021：企業別、地域別、種類・用途別 The Colorectal Cancer Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の統合プラットフォーム展開ソリューション（IPDS）市場 2021：企業別、地域別、種類・用途別 The Integrated Platform Deployment Solution (IPDS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- 世界のコネクテッドレイルソリューション市場 2021：企業別、地域別、種類・用途別 The Connected Rail Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界のエネルギー貯蔵溶液市場 2021：企業別、地域別、種類・用途別 The Energy Storage Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…